These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2999553)

  • 21. Multiple sequential biomarkers in monitoring patients with carcinoma of the lung.
    Aroney RS; Dermody WC; Aldenderfer P; Parsons P; McNitt K; Marangos PJ; Whitacre MY; Ruddon RW; Wiernik PH; Aisner J
    Cancer Treat Rep; 1984 Jun; 68(6):859-66. PubMed ID: 6329508
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclic alternating chemotherapy for small cell carcinoma of the lung.
    Murray N; Shah A; Wilson K; Goldie J; Voss N; Fryer C; Klimo P; Coy P; Hadzic E; Gudauskas G
    Cancer Treat Rep; 1985 Nov; 69(11):1241-2. PubMed ID: 3004724
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Tumor markers in bronchial cancer: do they have a role in daily practice?].
    Feintrenie X; Briancon S; Pichene M; Lamy P
    Rev Pneumol Clin; 1984; 40(6):345-54. PubMed ID: 6085181
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Small cell bronchial cancer. Comparison of results of weekly polychemotherapy using multiple drugs with standard chemotherapy. European Lung Cancer Working Party].
    Sculier JP; Paesmans M; Bureau G; Dabouis G; Libert P; Vandermoten G; Van Cutsem O; Berchier MC; Ries F; Michel J
    Rev Mal Respir; 1994; 11(3):257-61. PubMed ID: 8041988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Small cell carcinoma of bladder: a single-center prospective study of 25 cases treated in analogy to small cell lung cancer.
    Bex A; Nieuwenhuijzen JA; Kerst M; Pos F; van Boven H; Meinhardt W; Horenblas S
    Urology; 2005 Feb; 65(2):295-9. PubMed ID: 15708041
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Markov model and markers of small cell lung cancer: assessing the influence of reversible serum NSE, CYFRA 21-1 and TPS levels on prognosis.
    Boher JM; Pujol JL; Grenier J; Daurès JP
    Br J Cancer; 1999 Mar; 79(9-10):1419-27. PubMed ID: 10188885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A study of immunoreactive calcitonin (CT), adrenocorticotropic hormone (ACTH) and carcinoembryonic antigen (CEA) in lung cancer and other malignancies.
    Krauss S; Macy S; Ichiki AT
    Cancer; 1981 May; 47(10):2485-92. PubMed ID: 6268270
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of cisplatin, cyclophosphamide, vincristine, and doxorubicin for the treatment of non-small cell lung cancer.
    Lindgren D; Cadman E; Erichson R; Grann V; Sachs K
    Cancer Treat Rep; 1984 Sep; 68(9):1159-61. PubMed ID: 6090015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High plasma D-dimer level is associated with decreased survival in patients with lung cancer.
    Altiay G; Ciftci A; Demir M; Kocak Z; Sut N; Tabakoglu E; Hatipoglu ON; Caglar T
    Clin Oncol (R Coll Radiol); 2007 Sep; 19(7):494-8. PubMed ID: 17513096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preoperative serum carcinoembryonic antigen level is a prognostic factor in women with early non-small-cell lung cancer.
    Hsu WH; Huang CS; Hsu HS; Huang WJ; Lee HC; Huang BS; Huang MH
    Ann Thorac Surg; 2007 Feb; 83(2):419-24. PubMed ID: 17257963
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adriamycin, cyclophosphamide and etoposide (ACE) in the treatment of small cell lung cancer.
    Ardizzoni A; Canobbio L; Pronzato P; Repetto L; Serrano J; Benvenuto F; Simonassi C; Baracco F; Faravelli B; Nosenzo M
    Chemioterapia; 1986 Dec; 5(6):416-9. PubMed ID: 3026668
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Combination chemotherapy and radiotherapy in small cell carcinoma of the lung].
    Yoshida S; Ogata T; Homma T; Kikuchi K; Masuda H; Matsuoka T; Sugiyama K; Noguchi Y; Yoneda S; Fukuda T
    Gan To Kagaku Ryoho; 1986 Jul; 13(7):2331-6. PubMed ID: 3015041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination chemotherapy for small cell lung cancer.
    Sufarlan AW; Zainudin BM
    Med J Malaysia; 1993 Jun; 48(2):166-70. PubMed ID: 8394502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Value of C-reactive protein determination in small cell lung cancer].
    Arpin D; Trillet-Lenoir V; Lasset C; Souquet PJ; Riou R; Yoanidis I; Guidollet J; Cordier JF; Brune J
    Bull Cancer; 1993 Dec; 80(12):1063-8. PubMed ID: 8081044
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of combination chemotherapy programs in advanced adenocarcinoma-large cell carcinoma of the lung: a North Central Cancer Treatment Group study.
    Krook JE; Fleming TR; Eagan RT; Cullinan S; Pfeifle D; Elliott T; Etzell P
    Cancer Treat Rep; 1984 Mar; 68(3):493-8. PubMed ID: 6322987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Random prospective study cyclophosphamide, doxorubicin, and methotrexate (CAM) combination chemotherapy versus single-agent sequential chemotherapy in non small cell lung cancer.
    Einhorn LH; Williams SD; Stevens EE; Bond WH; Chenoweth L
    Cancer Treat Rep; 1982 Dec; 66(12):2005-11. PubMed ID: 6291763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic factors in limited-stage small cell lung cancer of patients treated with combined modality approach.
    Cetingöz R; Cetinayak HO; Sen RC; Demiral AN; Akkoçlu A; Osma E; Kargi A; Oztop I; Onen A; Kinay M;
    J BUON; 2006; 11(1):31-7. PubMed ID: 17318949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pro-gastrin-releasing peptide (ProGRP) and neuron specific enolase (NSE) in therapy control of patients with small-cell lung cancer.
    Schneider J; Philipp M; Salewski L; Velcovsky HG
    Clin Lab; 2003; 49(1-2):35-42. PubMed ID: 12593474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic significance of preoperative serum carcinoembryonic antigen level in lung adenocarcinoma but not squamous cell carcinoma.
    Tomita M; Matsuzaki Y; Edagawa M; Shimizu T; Hara M; Onitsuka T
    Ann Thorac Cardiovasc Surg; 2004 Apr; 10(2):76-80. PubMed ID: 15209547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prognostic value of carcinoembryonic antigen in T1N1M0 and T2N1M0 non-small cell carcinoma of the lung.
    Fukai R; Sakao Y; Sakuraba M; Oh S; Shiomi K; Sonobe S; Saitoh Y; Miyamoto H
    Eur J Cardiothorac Surg; 2007 Sep; 32(3):440-4. PubMed ID: 17643308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.